Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence

[1] Chen MF(1999)Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment J Gastroenterol Hepatol 14 1144-1149

[2] Razumilava N(2014)Cholangiocarcinoma Lancet 383 2168-2179

[3] Gores GJ(2004)The epidemiology of cholangiocarcinoma Semin Liver Dis 24 115-125

[4] Shaib Y(2005)Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma World J Surg 29 894-898

[5] El-Serag HB(2001)Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 1353-1357

[6] Jan YY(2016)Molecular pathogenesis and targeted therapies for intrahepatic Cholangiocarcinoma Clin Cancer Res 22 291-300

[7] Yeh CN(2011)Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J Clin Oncol 29 3140-3145

[8] Yeh TS(2007)Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 755-762

[9] Hwang TL(2009)Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans Hepatology 49 116-123

[10] Chen MF(2008)Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study Am J Gastroenterol 103 1716-1720

[1] Chen MF(1999)Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment J Gastroenterol Hepatol 14 1144-1149

[2] Razumilava N(2014)Cholangiocarcinoma Lancet 383 2168-2179

[3] Gores GJ(2004)The epidemiology of cholangiocarcinoma Semin Liver Dis 24 115-125

[4] Shaib Y(2005)Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma World J Surg 29 894-898

[5] El-Serag HB(2001)Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 1353-1357

[6] Jan YY(2016)Molecular pathogenesis and targeted therapies for intrahepatic Cholangiocarcinoma Clin Cancer Res 22 291-300

[7] Yeh CN(2011)Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J Clin Oncol 29 3140-3145

[8] Yeh TS(2007)Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 755-762

[9] Hwang TL(2009)Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans Hepatology 49 116-123

[10] Chen MF(2008)Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study Am J Gastroenterol 103 1716-1720